VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HCAHCA Healthcare, Inc.
$391.68$86.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHCABalance Sheet

HCA Healthcare, Inc. (HCA) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial position has weakened, with total equity deteriorating to a negative $6.3B and total debt climbing to $49.8B as of 2026Q1.

HCA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets16.05B13.56B16.41B14.93B13.64B13.54B12.33B11.2B10.21B9.98B9.09B9.23B8.93B8.04B7.76B7.23B6.92B6.58B6.3B6.21B6.08B5.21B4.68B4.82B4.5B4.14B4.45B3.6B3.86B4.42B4.41B
Cash & Short-Term Investments940M1.04B2.02B935M908M1.45B1.79B621M502M732M646M741M566M414M705M373M411M312M465M393M634M336M258M115M161M85M314M190M297M110M113M
Cash Only940M1.04B1.93B935M908M1.45B1.79B621M502M732M646M741M566M414M705M373M411M312M465M393M634M336M129M115M161M85M314M190M297M110M113M
Short-Term Investments0088M0000000000000000000000000000
Accounts Receivable11.32B10.87B10.75B9.96B8.89B8.1B7.05B7.38B6.79B6.5B5.83B5.89B5.69B5.21B4.67B4.53B3.83B3.69B3.78B3.9B3.71B3.33B3.08B3.1B2.79B2.51B2.41B2.05B2.25B3.05B2.84B
Days Sales Outstanding51.4652.4755.5855.9553.8850.2949.9452.4753.0954.4151.2554.1756.355.6151.6550.945.5844.8448.6352.9353.0849.7347.8851.851.5851.0952.7244.9443.8659.2352.1
Inventory1.68B1.65B1.74B2.02B2.07B1.99B2.02B1.85B1.73B1.57B1.5B1.44B1.28B1.18B1.09B1.05B897M802M737M710M669M616M577M520M462M423M396M383M434M452M441M
Days Inventory Outstanding12.5913.6315.1318.7320.3719.9988.3279.5881.8578.4879.1379.1374.5572.0869.3474.286660.1358.2358.9656.554.4953.99-------21.35
Other Current Assets2.11B01.9B2.01B1.78B2.01B1.46B1.35B1.19B1.17B1.11B1.16B1.39B1.24B1.3B1.27B1.78B1.77B1.32B1.21B1.07B931M1.14B1.09B1.09B1.12B1.33B973M887M807M806M
Total Non-Current Assets45.4B47.16B43.1B41.28B38.8B37.2B35.16B33.86B28.99B26.62B24.67B23.51B22.27B20.79B20.31B19.66B16.93B17.55B17.98B17.82B17.6B17.01B16.78B16.24B14.24B13.59B13.12B13.29B15.57B17.58B16.86B
Property, Plant & Equipment33.57B31.14B31.55B29.92B27.64B26.18B25.22B24.55B19.76B17.89B16.35B15.01B14.36B13.62B13.19B12.83B11.35B11.43B11.53B11.44B11.67B11.38B11.4B11.06B9.72B8.92B8.48B8.49B9.45B10.23B10.4B
Fixed Asset Turnover2.36x2.43x2.24x2.17x2.18x2.24x2.04x2.09x2.36x2.44x2.54x2.64x2.57x2.51x2.50x2.53x2.70x2.63x2.46x2.35x2.18x2.15x2.06x1.97x2.03x2.01x1.97x1.96x1.98x1.84x1.91x
Goodwill009.77B9.61B9.29B9.14B8.21B7.94B7.61B7.04B6.33B6.34B6.02B00002.58B2.58B2.63B2.6B2.63B2.54B2.48B1.99B2.51B00000
Intangible Assets10.5B10.29B323M339M359M403M369M330M342M359M374M393M399M5.9B5.54B5.25B2.69B0000000002.41B2.05B2.25B3.05B2.84B
Long-Term Investments4.05B633M1.23B1.23B1.2B886M810M564M594M617M542M610M659M569M619M649M1.51B2.02B2.26B2.36B2.56B2.76B2.53B2.32B2.03B2.13B2.15B2.11B2.89B2.75B2.41B
Other Non-Current Assets326M5.09B230M184M298M598M546M480M690M710M1.07B1.16B620M703M969M931M1.38B1.53B1.61B1.39B762M244M313M378M487M486M330M368M318M1.08B550M
Total Assets61.45B60.72B59.51B56.21B52.44B50.74B47.49B45.06B39.21B36.59B33.76B32.74B31.2B28.83B28.07B26.9B23.85B24.13B24.28B24.02B23.68B22.23B21.46B21.06B18.74B17.73B17.57B16.89B19.43B22B21.27B
Asset Turnover1.27x1.25x1.19x1.16x1.15x1.16x1.09x1.14x1.19x1.19x1.23x1.21x1.18x1.19x1.18x1.21x1.29x1.25x1.17x1.12x1.08x1.10x1.09x1.04x1.05x1.01x0.95x0.99x0.96x0.86x0.94x
Asset Growth %9.03%2.03%5.87%7.2%3.34%6.85%5.4%14.92%7.14%8.4%3.1%4.95%8.21%2.69%4.38%12.77%-1.16%-0.61%1.06%1.48%6.52%3.54%1.91%12.39%5.7%0.92%4.04%-13.09%-11.69%3.43%6.94%
Total Current Liabilities19.26B16.35B15.18B12.65B9.9B9.58B8.7B7.76B7.57B6.16B5.83B5.52B5.48B5.7B6.17B5.55B4.27B4.31B3.91B3.85B3.58B3.9B3.17B3.17B3.74B3.18B4.14B3.33B3.56B2.77B2.95B
Accounts Payable4.81B4.66B4.28B4.23B4.24B4.11B3.54B2.9B2.58B2.61B2.32B2.17B2.04B1.8B1.77B1.6B1.54B1.46B1.37B1.37B1.42B1.48B855M877M809M755M693M657M784M929M790M
Days Payables Outstanding33.5338.4537.2339.2341.7541.38154.17125.02121.78130.01122.04119.32118.62110.23112.88112.55113.08109.47108.24113.78119.5131.2880-------38.24
Short-Term Debt8.53B6.74B4.7B2.42B370M237M209M145M788M200M216M233M338M786M1.44B1.41B592M846M404M308M293M586M486M665M446M807M1.12B1.16B1.07B132M201M
Deferred Revenue (Current)0000000000000000000000000000000
Other Current Liabilities3.9B2.42B910M867M794M549M547M528M459M67M0000000000000000000046M
Current Ratio0.83x0.83x1.08x1.18x1.38x1.41x1.42x1.44x1.35x1.62x1.56x1.67x1.63x1.41x1.26x1.30x1.62x1.52x1.61x1.61x1.70x1.34x1.48x1.52x1.20x1.30x1.08x1.08x1.09x1.60x1.50x
Quick Ratio0.75x0.73x0.97x1.02x1.17x1.21x1.18x1.20x1.12x1.36x1.30x1.41x1.40x1.20x1.08x1.11x1.41x1.34x1.42x1.43x1.51x1.18x1.29x1.36x1.08x1.17x0.98x0.96x0.96x1.43x1.35x
Cash Conversion Cycle30.5227.6533.4835.4532.4928.9-15.917.0213.162.878.3513.9812.2317.468.1112.63-1.5-4.49-1.38-1.88-9.92-27.0521.87-------35.21
Total Non-Current Liabilities45.17B47.14B43.78B42.5B42.61B39.67B35.89B37.87B34.56B35.43B33.56B33.27B32.22B30.06B30.24B28.36B30.38B27.8B29.63B29.78B30.57B12.64B13.07B11.01B8.69B9.22B8.45B7.17B7.52B11.14B8.88B
Long-Term Debt39.49B41.6B38.33B37.17B37.13B33.77B30.8B33.58B32.03B32.86B31.16B30.25B29.09B27.59B27.5B25.64B27.63B24.82B26.59B27B28.11B9.89B10.04B8.04B6.5B6.55B5.63B5.28B5.68B9.28B6.78B
Capital Lease Obligations7.39B1.85B1.86B1.9B2.33B2.33B1.67B1.5B000000000000-125M0000000000
Deferred Tax Liabilities0000000000000001.72B1.61B1.77B1.78B1.38B1.02B1.41B1.75B1.65B999M000002.1B
Other Non-Current Liabilities3.86B3.69B3.58B3.42B3.14B3.57B3.43B2.79B2.52B2.57B2.4B3.02B3.13B2.47B2.75B2.71B2.6B2.97B2.89B2.61B1.31B1.34B1.28B1.31B1.19B2.67B2.82B1.89B1.84B1.87B0
Total Liabilities64.43B63.49B58.96B55.15B52.51B49.25B44.6B45.62B42.13B41.59B39.39B38.79B37.7B35.76B36.42B33.91B34.65B32.11B33.54B33.63B34.14B16.53B16.25B14.17B12.43B12.4B12.59B10.51B11.08B13.92B11.83B
Total Debt49.84B50.2B45.24B41.86B40.2B36.73B33.06B35.57B32.82B33.06B31.38B30.49B29.43B28.38B28.93B27.05B28.23B25.67B26.99B27.31B28.41B10.47B10.53B8.71B6.94B7.36B6.75B6.44B6.75B9.41B6.98B
Net Debt48.91B49.16B43.3B40.92B39.29B35.27B31.26B34.95B32.32B32.33B30.73B29.75B28.86B27.96B28.23B26.68B27.81B25.36B26.52B26.91B27.77B10.14B10.27B8.59B6.78B7.28B6.44B6.25B6.46B9.3B6.87B
Debt / Equity-16.74x-81.51x39.49x-24.66x11.43x--------------1.84x2.02x1.26x1.10x1.38x1.36x1.01x0.81x1.16x0.74x
Debt / EBITDA3.20x3.24x3.26x3.29x3.34x2.93x3.31x3.62x3.68x4.04x3.84x3.87x3.98x4.34x4.45x4.66x5.05x4.91x6.20x6.24x6.72x2.45x2.66x2.23x2.27x2.25x0.38x0.37x0.37x3.91x1.72x
Net Debt / EBITDA3.14x3.17x3.12x3.22x3.27x2.82x3.13x3.56x3.62x3.95x3.76x3.78x3.91x4.27x4.35x4.60x4.98x4.85x6.10x6.15x6.57x2.37x2.59x2.20x2.22x2.22x0.37x0.36x0.36x3.86x1.69x
Interest Coverage5.29x5.37x5.14x4.98x5.94x7.46x4.50x3.84x4.02x3.64x4.08x3.65x3.24x2.79x2.80x3.30x2.06x2.43x1.58x1.54x2.74x4.28x4.50x--------
Total Equity-2.98B-2.77B555M1.06B-73M1.49B2.89B-565M-2.92B-5B-5.63B-6.05B-6.5B-6.93B-8.34B-7.01B-10.79B-7.98B-9.26B-9.6B-10.47B5.69B5.22B6.89B6.31B5.33B4.98B6.38B8.35B8.09B9.45B
Equity Growth %-1746.33%-599.28%-47.64%1552.05%-104.9%-48.51%611.86%80.64%41.58%11.33%6.83%6.96%6.21%16.94%-18.92%35.02%-35.3%13.84%3.54%8.28%-283.92%9.11%-24.29%9.12%18.55%6.99%-21.99%-23.56%3.22%-14.39%20.3%
Book Value per Share-13.14-12.012.123.83-0.254.538.37-1.62-8.21-13.42-14.23-14.17-14.43-15.00-18.16-14.14-24.68-22.88-26.55-27.53-25.5212.7210.7813.5012.059.928.989.5712.9412.2013.93
Total Shareholders' Equity-6.3B-6.03B-2.5B-1.77B-2.77B-933M572M-2.81B-4.95B-6.81B-7.3B-7.6B-7.89B-8.27B-9.66B-8.26B-11.93B-8.99B-10.26B-10.54B-11.37B4.86B4.41B6.21B5.7B4.76B4.41B5.62B7.58B7.25B8.61B
Common Stock2M2M3M3M3M3M3M3M3M4M4M4M4M4M4M4M4M1M1M1M1M4M4M5M5M5M5M6M6M6M7M
Retained Earnings-5.98B-5.72B-2.12B-1.35B-2.28B-532M777M-2.35B-4.57B-6.53B-6.97B-7.34B-7.58B-9.4B-10.96B-9.42B-11.89B-8.76B-9.82B-10.48B-11.39B4.73B4.21B6.03B5.53B4.73B4.34B4.6B3.99B3.66B4.02B
Treasury Stock0000000000000000000000000000000
Accumulated OCI-327M-305M-387M-425M-490M-404M-502M-460M-381M-278M-338M-265M-323M-257M-457M-440M-428M-450M-604M-172M16M130M193M168M73M18M52M53M80M92M-5.32B
Minority Interest3.33B3.26B3.05B2.83B2.69B2.42B2.32B2.24B2.03B1.81B1.67B1.55B1.4B1.34B1.32B1.24B1.13B1.01B995M938M907M828M809M680M611M563M572M763M765M836M836M

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Negative equity and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Erosion of Shareholder Equity Base

As reported in recent financial filings, HCA's total equity has deteriorated into a negative position of $6.3B by 2026Q1, a significant decline from the $1.8B deficit observed in 2023Q4, signaling a potential long-term weakening of the company's net asset position relative to its total liabilities.

The consistent decline in equity appears to be driven by aggressive capital allocation policies, specifically share repurchases, which have outpaced retained earnings growth. Investors should monitor whether this trend of negative equity persists, as it may indicate that the company is effectively leveraging its balance sheet to support valuation rather than building intrinsic book value.

Rising Leverage Amid Capital Intensity

Based on the provided balance sheet data, HCA's total debt has climbed to $49.8B in 2026Q1 from $41.9B in 2023Q4, reflecting a persistent reliance on external financing to fund both operational requirements and ongoing capital expenditures across its regional hospital clusters.

The steady accumulation of debt suggests that the company is prioritizing expansion and shareholder returns over deleveraging, even as interest rate environments remain uncertain. This debt-heavy structure warrants further investigation into the maturity profile and the potential for refinancing risk if cash flow generation from core hospital operations continues to face margin pressure.

Capital Intensive Asset Base Expansion

According to quarterly balance sheet disclosures, HCA's net property, plant, and equipment (PPE) has grown to $33.6B in 2026Q1, up from $29.9B in 2023Q4, confirming the company's commitment to maintaining its extensive physical footprint despite the ongoing shift toward outpatient care models.

The growth in PPE relative to total assets underscores the capital-intensive nature of the hospital business, where maintaining high-acuity facilities is essential to the cluster strategy. However, the rising asset base requires consistent, high-margin throughput to justify the depreciation and maintenance costs, which may be increasingly difficult to achieve in a competitive reimbursement landscape.

Tightening Liquidity and Cash Buffers

As indicated by recent financial statements, HCA's current ratio has compressed to 0.83 in 2026Q1 from a peak of 1.18 in 2023Q4, suggesting a narrowing margin of safety for meeting short-term obligations amidst fluctuating working capital requirements and ongoing operational cost pressures.

The decline in the current ratio appears to reflect a reduced cash buffer, which may limit the company's flexibility to respond to unexpected regulatory or operational shocks. This tightening liquidity profile warrants close monitoring, as it suggests that the company is operating with less room for error in its day-to-day cash management.

HCA — Frequently Asked Questions

Quick answers to the most common questions about buying HCA stock.

What are the total assets of HCA Healthcare, Inc. (HCA)?

As of 2025, HCA Healthcare, Inc. (HCA) had total assets of $60.72B including $13.56B in current assets.

How much debt does HCA Healthcare, Inc. (HCA) have?

HCA Healthcare, Inc. (HCA) carries total debt of $50.20B, offset by $1.04B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of HCA Healthcare, Inc.?

HCA Healthcare, Inc. (HCA) has total shareholders' equity (book value) of $-6027.0M ($-12.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is HCA Healthcare, Inc.'s current ratio and liquidity?

HCA Healthcare, Inc. (HCA) reported a current ratio of 0.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.